Genetic Factors That Affect Tumorigenesis in NF1

Abstract

Neurofibromatosis type 1 predisposes to the growth of both benign and malignant tumors. Genetic factors, in addition to inactivation of the NF1 gene itself, clearly play a role in tumor development. Our research is focused on identifying specific DNA sequences and genetic mechanisms important in the development of cutaneous neurofibromas. We are analyzing NF1 microdeletions, which are associated with an early onset, and subsequent heavy burden, of cutaneous neurofibromas. We identified recombination hotspots where breakpoints in ^75% of patients with NF1 microdeletions occur and developed assays that detect microdeletions in a patient blood sample. Near the recombination hotspots where microdeletions occur, we identified unique sequence elements that may mediate recombination at these sites and make some chromosomes susceptible to NF1 microdeletion. Unexpectedly, we found that NF1 microdeletions that arise in a somatic cell during early embryogenesis occur at different sites. An understanding of how NF1 microdeletions occur, whether some individuals are more susceptible, and why they potentiate the development of neurofibromas is important for patient care, genetic counseling, and the design of effective pharmacological intervention strategies.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2001
Accession Number
ADA400492

Entities

People

  • Karen G. Stephens

Organizations

  • University of Washington

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Cancer
  • Cells
  • Chromosomes
  • Diseases And Disorders
  • Genes
  • Genetic Phenomena
  • Genetic Structures
  • Genetics
  • Genotypes
  • Health Services
  • Medical Genetics
  • Molecular Genetics
  • Neoplasms
  • Neuromuscular Diseases
  • Patient Care
  • Sequences

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology